ArticleFrontiers in pharmacology2025

Targeted degradation of EGFR 19Del by PROTACs suppresses tumor growth in non-small-cell lung cancer.

Lianhua Piao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.